McAnear Justin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Aug 4, 2021
- Accession no.
- 0001209191-21-049650
- Filed
- Aug 4, 2021
- Trade date
- Aug 2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.80M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McAnear Justin J.CIK 0001786386 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Class A Common Stock | MOption exerciseAcquired | +10,000 | $5.04 | +$50,400 | 49,370 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −1,698 | $178.35F2 | −$302,838.3 | 47,672 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −2,202 | $179.28F3 | −$394,774.56 | 45,470 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −2,298 | $180.29F4 | −$414,306.42 | 43,172 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −2,302 | $181.31F5 | −$417,375.62 | 40,870 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −700 | $182.16F6 | −$127,512 | 40,170 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −500 | $183.30F7 | −$91,650 | 39,670 | Direct | |
| Aug 2, 2021 | Class A Common Stock | SSaleDisposed | −300 | $184.52F8 | −$55,356 | 39,370 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Class A Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 400,159 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $177.80 to $178.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $178.865 to $179.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $179.89 to $180.865. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $180.89 to $181.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $181.93 to $182.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $182.93 to $183.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $184.19 to $184.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.